Amy W. Schulman

Companies

• Elevance Health, Inc.Board member Jan 14, 2026 to now¹
• Fractyl (United States)Board member Feb 1, 2024 to now²
• Alnylam PharmaceuticalsBoard member Jul 2, 2014 to now³
• SQZ Biotechnologies CoBoard member Oct 29, 2020 to Jun 15, 2023⁴
• Hudson Executive Investment Corp. IIBoard member Jan 25, 2021 to Apr 14, 2021⁵
• Korsana Biosciences, Inc.Board member Apr 3, 2019 to Jun 18, 2020⁶
• Talkspace, Inc.Board member Jun 8, 2020 to Jun 8, 2020⁷
• Ironwood PharmaceuticalsBoard member Jan 4, 2017 to Apr 3, 2019⁸
• X4 Pharmaceuticals, IncBoard member Nov 15, 2017 to Jun 7, 2018⁹
• PfizerSenior Vice President Jun 27, 2008 to Jan 2, 2014¹⁰
• ZoetisBoard member Jan 31, 2013 to Feb 8, 2013¹¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Pfizer PFE223,797 shares¹²$6.7M at $29.78May 16, 2013
• Alnylam Pharmaceuticals ALNY24,049 shares¹³$5.7M at $235.58May 20, 2026
• Elevance Health, Inc. ELV781 shares¹⁴$343.6K at $439.98May 13, 2026
• FUFractyl (United States) GUTS8,550 shares¹⁵$11.9K at $1.39Mar 13, 2025
• SBSQZ Biotechnologies Co216,664 shares¹⁶Dec 23, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

• May 20, 2026Granted 838 shares of Alnylam Pharmaceuticals¹³
• May 13, 2026Granted 563 shares of Elevance Health, Inc.¹⁴
• May 13, 2026Exercised options 11,250 shares at $70.20 of Alnylam Pharmaceuticals¹⁷
• Mar 12, 2026Sold 26 shares at $287.50 of Elevance Health, Inc.¹⁸
• Feb 2, 2026Granted 218 shares of Elevance Health, Inc.¹⁹
• May 8, 2025Granted 775 shares of Alnylam Pharmaceuticals²⁰
• Mar 13, 2025Exercised options 2,750 shares at $131.21 of Alnylam Pharmaceuticals²¹
• Mar 13, 2025Bought 8,550 shares at $1.17 of Fractyl (United States)¹⁵
• Jun 25, 2024Sold 8,500 shares at $240.00 of Alnylam Pharmaceuticals²²
• Jun 25, 2024Exercised options 8,500 shares at $131.21 of Alnylam Pharmaceuticals²²
• May 29, 2024Sold 63 shares at $149.76 of Alnylam Pharmaceuticals²³
• May 29, 2024Sold 11,516 shares at $148.93 of Alnylam Pharmaceuticals²³
• May 29, 2024Sold 10,121 shares at $148.21 of Alnylam Pharmaceuticals²³
• May 29, 2024Exercised options 30,000 shares at $66.83 of Alnylam Pharmaceuticals²³
• Feb 23, 2023Exercised options 136 shares of Alnylam Pharmaceuticals²⁴
• Dec 22, 2021Exercised options 6,581 shares at $4.59 of SQZ Biotechnologies Co¹⁶
• Dec 22, 2021Exercised options 7,458 shares at $4.59 of SQZ Biotechnologies Co¹⁶
• Dec 22, 2021Exercised options 10,091 shares at $2.02 of SQZ Biotechnologies Co¹⁶
• Dec 13, 2021Bought 1,850 shares at $10.94 of SQZ Biotechnologies Co²⁵
• Dec 13, 2021Bought 1,850 shares at $10.88 of SQZ Biotechnologies Co²⁵
• May 15, 2013Sold 10,598 shares at $29.35 of Pfizer¹²
• May 15, 2013Sold 10,408 shares at $29.41 of Pfizer¹²
• May 15, 2013Sold 5,700 shares at $29.32 of Pfizer¹²
• May 15, 2013Sold 5,268 shares at $29.34 of Pfizer¹²
• May 15, 2013Sold 4,701 shares at $29.40 of Pfizer¹²